Evidence map›Paper›PMID 40045780›Full record

ReviewPhilosophical transactions of the Royal Society of London. Series B, Biological sciences2025

Ribosomes: from conserved origin to functional/medical mobility and heterogeneity.

Andre Rivalta, Disha-Gajanan Hiregange, Tanaya Bose, K Shanmugha Rajan, Ada Yonath, Ella Zimmerman, Miriam Waghalter, Gil Fridkin, Irene Martinez-Roman, Liat Rosenfield and 3 more

Abstract readReview
In one paragraph

Review in Philosophical transactions of the Royal Society of London. Series B, Biological sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. RiboScreenBiomedicines · 2026
    Review
  3. Article
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Andre RivaltaDepartment of Chemical and Structural Biology, Weizmann Institute of Science, Rehovot, Israel.
Disha-Gajanan HiregangeDepartment of Chemical and Structural Biology, Weizmann Institute of Science, Rehovot, Israel.
Tanaya BoseDepartment of Chemical and Structural Biology, Weizmann Institute of Science, Rehovot, Israel.
K Shanmugha RajanDepartment of Chemical and Structural Biology, Weizmann Institute of Science, Rehovot, Israel.ORCID 0000-0003-4826-9802
Ada YonathDepartment of Chemical and Structural Biology, Weizmann Institute of Science, Rehovot, Israel.ORCID 0000-0002-1856-6964
Ella ZimmermanDepartment of Chemical and Structural Biology, Weizmann Institute of Science, Rehovot, Israel.
Miriam WaghalterDepartment of Chemical and Structural Biology, Weizmann Institute of Science, Rehovot, Israel.
Gil FridkinDepartment of Organic Chemistry, Israel Institute for Biological Research, Ness Ziona, Israel.
Irene Martinez-RomanDepartment of Chemical and Structural Biology, Weizmann Institute of Science, Rehovot, Israel.
Liat RosenfieldDepartment of Chemical and Structural Biology, Weizmann Institute of Science, Rehovot, Israel.
Aliza FedorenkoDepartment of Chemical and Structural Biology, Weizmann Institute of Science, Rehovot, Israel.
Anat BashanDepartment of Chemical and Structural Biology, Weizmann Institute of Science, Rehovot, Israel.
Hagith YonathHuman Genetics Institute and Internal Medicine A, Sheba Medical Center, Ramat-Gan and Tel-Aviv University, Tel Aviv, Israel.

Funding

Kimmelman Center, WIS
6 · The paper itself

Abstract

Ribosomes, the molecular machines that translate the genetic code from mRNA into proteins in all living cells, are highly structurally conserved across all domains of life and hence are believed to have evolved from a structurally unified pocket. Initially perceived as uniform cellular factories for protein synthesis, currently, ribosomes have emerged as more complex entities. Structural, medical and biochemical studies, including ours, have revealed significant variability in their compositions across tissues, species, functions and developmental stages, highlighting their multifunctional potential. Moreover, the diversity of ribosomes, their components and their associated biological factors challenge the traditional perception of uniform interactions under various conditions, including stress, and expose their mobility and heterogeneity. Evidence for their functional diversity can be seen even in modifications of ribosomal genes, where minor changes may play critical roles under stress or may lead to diseases called ribosomopathies, including Diamond-Blackfan anaemia, some types of cancer and Alzheimer's disease. Thus, through in-depth structural explorations, we improve the understanding of the mechanisms regulating protein biosynthesis in response to various environmental stressors. These findings should potentially reshape the perceptions of the various ribosomal roles.This article is part of the discussion meeting issue 'Ribosome diversity and its impact on protein synthesis, development and disease'.

Indexed as

Protein BiosynthesisRibosomesAnimalsHumansgenetic diseasesprotoribosomeribosomal mutationsribosome heterogeneityribosome mobilityribosomopathies

Identifiers

PMID40045780
PMCPMC11883434

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.